<DOC>
	<DOCNO>NCT00156195</DOCNO>
	<brief_summary>The objective study determine long-term safety asoprisnil woman abnormal uterine bleeding associate uterine fibroid .</brief_summary>
	<brief_title>Study Evaluate Safety Asoprisnil Treatment Uterine Fibroids</brief_title>
	<detailed_description>No medical therapy currently available long-term treatment abnormal uterine bleeding associate uterine fibroid woman many woman must resort surgery relief . The objective study determine long-term safety asoprisnil 10 25 mg tablet administer daily 12 month woman abnormal uterine bleeding associate uterine fibroid initial 12 month M01-390 M01-394 . The safety endpoint study base assessment endometrium , ovarian cyst ( applicable ) , bone lipid profile , adverse event , change baseline laboratory value vital sign . Some subject receive asoprisnil develop endometrial change . As result , dose prematurely discontinue subject . To ensure safety , subject remain study undergo schedule study procedure . In subject , endometrial change reverse asoprisnil discontinuation .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<criteria>Women complete 12 month treatment study M01390 study M01394 Visit 12 procedure , respectively Otherwise good health Premenopausal base Estrogen FSH level Agrees use double barrier method contraception Adequate endometrial biopsy significant histological disorder Any abnormal lab procedure result ( ) studydoctor considers important Significant gynecological disorder confirm endometrial polyp Hemoglobin &lt; 8.0 g/dL History bloodclotting disorder Any prior surgical and/or invasive procedure ( ) uterine fibroid result either cure make symptom go away .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Symptomatic Uterine Fibroids</keyword>
	<keyword>Excessive Uterine Bleeding</keyword>
	<keyword>Uterine Hemorrhage</keyword>
	<keyword>asoprisnil</keyword>
</DOC>